Helene Myrtue Nielsen

发表

Epigenetics and cancer treatment.

L. Kristensen, Helene Myrtue Nielsen, L. Hansen, 2009, European journal of pharmacology.

Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors

David Taieb, Vessela N Kristensen, Anne Barlier, 2015, Endocrine-related cancer.

Sensitive Detection of KRAS Mutations Using Enhanced‐ice‐COLD‐PCR Mutation Enrichment and Direct Sequence Identification

Helene Myrtue Nielsen, J. Tost, Antoine Daunay, 2013, Human mutation.

Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing

L. Kristensen, Helene Myrtue Nielsen, L. Hansen, 2013, Scientific Reports.

Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome

L. Kristensen, Helene Myrtue Nielsen, K. Grønbæk, 2015, Oncotarget.

The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma

Helene Myrtue Nielsen, K. Grønbæk, C. Geisler, 2020, Dermatology.

DNA methylation based biomarkers: practical considerations and applications.

Helene Myrtue Nielsen, J. Tost, A. How Kit, 2012, Biochimie.

Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?

C. Hother, Helene Myrtue Nielsen, M. Treppendahl, 2013, Oncotarget.

Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.

L. Kristensen, Helene Myrtue Nielsen, L. Hansen, 2011, Lung cancer.

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations

L. Kristensen, Helene Myrtue Nielsen, L. Hansen, 2017, Scientific Reports.

Epigenetic changes in inflammatory and autoimmune diseases.

Helene Myrtue Nielsen, J. Tost, 2013, Sub-cellular biochemistry.